An official website of the United States government
Home
Name
WT-1 peptide vaccine
Alternate Names
OCV-501
Abbreviations
None
Category
Biologic therapy (BRM, immunotherapy)
Subcategory
Vaccine
NSC Number
None
Primary Site
Pleura
Histology
Malignant pleural mesothelioma
Remarks
March 4, 2016: The FDA granted Orphan Drug designation to the WT! Cancer Vaccine developed by SELLAS Life Science Group for the treatment of patients with malignant pleural mesothelioma. This was based on the positive results from phase II clinical trials. Phase IIb/III trials will be initiated.
CODING: code this vaccine in Other Treatment, assign code 2
CODING: code this vaccine in Other Treatment, assign code 2
Coding
Please see remarks for additional information
